 "Torrent Pharma hits new lifetime high on strong Q1 results")
Shares of Torrent Pharmaceuticals rallied 9% to Rs 1,520, also their new lifetime highs on the BSE in early morning trades, after the company reported a strong 75% year-on-year (YoY) rise in consolidated net profit at Rs 449 crore for the first quarter ended June 2015 (Q1), mainly on account of a new product launch in the US.
The drug company had posted a net profit of Rs 256 crore in the corresponding period of previous fiscal.
The company’s consolidated net revenues grew 75% Y-o-Y at Rs 1,947 crore for the quarter under review as against Rs 1,114 crore in the same quarter a year ago.
"The exceptional growth in the revenues and profits for the quarter is primarily on account of launch of a new product in the US market, which currently has limited competition," Torrent Pharmaceuticals said in a statement.
The EBITDA (earnings before interest, tax, depreciation and amortization) margins expanded to 50% in June quarter against 34% in year ago quarter.
At 09:25 AM, the stock was up 6% at Rs 1,484 on the BSE and has seen a combined 311,561 shares changing hands on the counter on the BSE and NSE.
The drug company had posted a net profit of Rs 256 crore in the corresponding period of previous fiscal.
The company’s consolidated net revenues grew 75% Y-o-Y at Rs 1,947 crore for the quarter under review as against Rs 1,114 crore in the same quarter a year ago.
"The exceptional growth in the revenues and profits for the quarter is primarily on account of launch of a new product in the US market, which currently has limited competition," Torrent Pharmaceuticals said in a statement.
The EBITDA (earnings before interest, tax, depreciation and amortization) margins expanded to 50% in June quarter against 34% in year ago quarter.
At 09:25 AM, the stock was up 6% at Rs 1,484 on the BSE and has seen a combined 311,561 shares changing hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%